Pharmaceutical Technology Excellence Awards 2025: Tech Mahindra
Tech Mahindra has built a broad presence across the life sciences value chain, from clinical and regulatory services through manufacturing …
Post
-
-
Transforming US drug access and production: MFN pricing deals and historic manufacturing investments
In November 2025, US President Donald Trump announced transformative actions to lower prescription drug costs and secure the pharmaceutical supply …
-
Nxera seeks schizophrenia programme buyer after Boehringer snub
Japan-based Nxera Pharma is seeking buyers for its Phase II-ready schizophrenia programme after Boehringer Ingelheim decided not to exercise a …
-
Takeda to seek approval of plaque psoriasis pill on Phase III trial data
Takeda’s once-daily oral plaque psoriasis (PsO) drug has met all its endpoints in two pivotal trials, with the company set …
-
Eli Lilly’s oral GLP-1RA maintains weight loss from injectable drugs
Eli Lilly’s oral glucagon-like peptide 1 receptor agonist (GLP-1RA), orforglipron, has proven its efficacy as a maintenance therapy in patients …
-
MHRA launches call for evidence on AI regulation in UK healthcare sector
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has launched a call for evidence seeking input from the healthcare …
-
J&J receives FDA approval for lung cancer therapy
Johnson & Johnson (J&J) has received the US Food and Drug Administration (FDA) approval for Rybrevant Faspro (amivantamab and hyaluronidase-lpuj), …
-
FDA approves meningioma label warning on Pfizer’s contraceptive injection
The US Food and Drug Administration (FDA) has approved a label change to Pfizer’s injectable contraceptive, Depo-Provera (medroxyprogesterone acetate), which …
-
BIOSECURE Act set for Trump’s signature after Congress approval
After years in regulatory limbo, the BIOSECURE Act looks set to be enacted into law, placing relationships between US and …
-
EC approves Incyte’s Minjuvi combo for follicular lymphoma
The European Commission (EC) has approved Incyte’s Minjuvi (tafasitamab) in conjunction with lenalidomide and rituximab for adults with relapsed or …
-
Alnylam plans $250m investment in Norton manufacturing facility, US
Alnylam Pharmaceuticals is set to invest $250m in the expansion of its facility in Norton, Massachusetts, US, to meet the …
-
CDC ends universal newborn hepatitis B vaccine recommendations
The US Centers for Disease and Prevention (CDC) no longer recommends that all US newborns receive the hepatitis B vaccine, …
-
GSK obtains FDA approval for Exdensur in severe asthma
GSK has secured approval from the US Food and Drug Administration (FDA) for its severe asthma add-on maintenance therapy, Exdensur …
-
Harbour BioMed and BMS sign multi-specific antibody collab
Harbour BioMed and Bristol Myers Squibb (BMS) have signed a multi-year, worldwide strategic partnership and licence agreement focused on multi-specific …
-
Precision medicine approaches needed in oncology to match evolving SoC
As the standard of care (SoC) for new drugs in oncology continues to improve, trials need to be designed with …
